E-Alerts
Podcasts
Movies
Movies
Youtube Button
Youtube
Traffic Button
Traffic
ListenLive Button
ListenLive

Wednesday

Mostly Sunny
Mostly Sunny
High: 78 °F
Low: 49 °F

Thursday

Partly Sunny
Partly Sunny
High: 80 °F
Low: 51 °F

Friday

Mostly Cloudy
Mostly Cloudy
High: 66 °F
Low: 44 °F

Coumadin Physician Sample Packs Recalled

khts_recallsBristol-Myers Squibb initiates a voluntary recall of 3 lots of physician sample blister packs of Coumadin® 1 mg tablets and 5 lots, of Coumadin 1 mg tablet hospital unit dose (HUD) blister packs.

The following lot numbers are included in this recall: Physician Sample Blister Packs: Lot# 9A48931A, 9A48931B, 9A48931C, expiration January 2012; HUD Blister Pack: Lot# 8F34006B, 8K44272A, 8K46168A, 9F44437A and 9K58012B with expiration dates between June 2011 and November 2012.

The recall is a precautionary measure based upon the company’s determination that some of the tablets, over time, may not meet specification for isopropanol. Isopropanol is used to maintain the active ingredient, Coumadin, in the crystalline state, and could affect the therapeutic levels of the active ingredient.


Don't miss a thing. Get breaking news alerts delivered right to your inbox
Coumadin is prescribed to treat or prevent blood clots. A decrease of active ingredient may increase the risk of clots which could lead to heart attack or stroke and if there is too much active ingredient, there is an increased risk of bleeding.

The recall only involves Coumadin 1 mg tablet blister-packs distributed in the U.S. This recall does not involve Coumadin 1 mg supplied in bottles or any other strengths and dosage forms of the product. Patients who may have product from the subject lots should contact their physicians to ensure that their anticoagulation therapy is not interrupted.

To date, the company has not received any reports of adverse events related to this issue. Bristol-Myers Squibb is committed to ensuring patient safety and is working to resolve this issue quickly and appropriately. The company has notified the U.S. Food and Drug Administration (FDA), and has issued recall communications to all physicians9 and other customers10 involved.

Any adverse reactions may also be reported to the FDA's MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov11.

Healthcare professionals and customers may call the following for assistance if they have further questions about the recall:

 

Recall Logistics Stericycle

1-877-546-0128

General Inquiries Bristol-Myers Squibb Customer Relations

1-800-332-2056 (option 1, then option 4)

Medical Inquiries Bristol-Myers Squibb Medical Information

1-800-321-1335 (option 5)

Recall Reimbursement Process Bristol-Myers Squibb Customer Service Operations

1-800-631-5244 (option 1, then option 5)